Investigator Site 21 — Palo Alto, California

Investigator Site 21 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 21 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 21?

Investigator Site 21 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 21 conducted?

Investigator Site 21 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Investigator Site 21 accredited by Crixeo Health?

Investigator Site 21 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 21?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.